Aptose Biosciences reschedules its special meeting of shareholders to a later date in January 2026. The Meeting was initially set for January 16, 2026, but will now be held at a later date. No changes are expected to the record date or the matters to be discussed at the Meeting.
Rescheduling Meeting
The special meeting of shareholders has been postponed with a new date to be announced in January 2026.
Continuation and Acquisition
The Meeting will include discussions on the Continuance and the subsequent acquisition by Hanmi Purchasers through a statutory plan of arrangement.
Recommendation for Shareholders
Aptose's board of directors unanimously recommends shareholders to vote FOR the special resolutions approving the Continuance and the Arrangement.
- Aptose determined to reschedule the Meeting pending final SEC clearance. The Company obtained an interim order from the Court of King's Bench of Alberta authorizing the Meeting on December 12, 2025.
Stay tuned for the new date and details of the special Meeting. Shareholders are encouraged to vote in favor of the proposed resolutions.